Crossmark

Applying regulatory science in traditional chinese medicines for improving public safety and facilitating innovation in China: a scoping review and regulatory implications

Crossref DOI link: https://doi.org/10.1186/s13020-021-00433-2

Published Online: 2021-02-16

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Liang, Zuanji

Lai, Yunfeng

Li, Meng

Shi, Junnan

Lei, Chi Ieong

Hu, Hao

Ung, Carolina Oi Lam https://orcid.org/0000-0003-1915-5099
License Information

Text and Data Mining valid from 2021-02-16

Version of Record valid from 2021-02-16
More Information

Article History

Received: 25 August 2020

Accepted: 6 February 2021

First Online: 16 February 2021

Ethics approval and consent to participate

: Not applicable.

: All of authors consent to publication of this work in Chinese Medicine.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below